Time Partitioning in Target Trial Emulation

Harold Tankpinou Zoumenou, Simon Ferreira, Charles Assaad, Nathanaël Lapidus, Daria Bystrova, Benjamin Glemain · 2026

Read Time Partitioning in Target Trial Emulation by Harold Tankpinou Zoumenou, Simon Ferreira, Charles Assaad, Nathanaël Lapidus, Daria Bystrova, Benjamin Glemain (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-15924.txt.

Introduction

Zoumenou and co-authors guide how finely to slice time in trial emulation. Time splits let analysts handle shifting confounders and immortal time bias. Two clinical scenarios anchor the study of split choices. Structural causal models formalize each research question first. A split can run too fine or too coarse. Fine splits bloat model size with no payoff. Coarse splits warp the causal structure and block estimation. Clone-censor-weight steps can fail when treatment acts inside a period. The team urges choosing splits with care.

Catalog record

CREATORHarold Tankpinou Zoumenou, Simon Ferreira, Charles Assaad, Nathanaël Lapidus, Daria Bystrova, Benjamin Glemain
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60684
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2603.15924

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Time Partitioning in Target Trial Emulation Harold Tankpinou Zoumenou, Simon Ferreira, Charles Assaad, Nathanaël Lapidus, Daria Bystrova, Benjamin Glemain Abstract In target trial emulation, time partitioning enables researchers to handle time-varying confounders and immortal time bias with appropriate methods. Based on two clinical scenarios, this study aimed to explore issues related to time partitioning and to provide guidance for trial emulation. After formalizing the research question within the framework of structural causal models, we show how a given time partitioning may be too fine or too coarse depending on the clinical context. When the partitioning is too fine, the dimensionality of the model is unnecessarily high. When the partitioning is too coarse, the resulting causal structure may hinder effect estimation. We also show that cloning–censoring–weighting may not be valid when treatment influences outcome within study periods, and we confirm this through simulations. In conclusion, we provide practical guidance for actively specifying an appropriate time partitioning in trial emulation, rather than using the available data resolution as a default. Keywords: Causal inference, Target trial emulation, Structural causal models, Clinical epidemiology 1 Introduction Target trial emulation now plays a central role in estimating treatment effects using observational data ( 14 ) . Representing treatment, confounders, and outcome as time-varying variables enables researchers to address time-dependent confounding and immortal time bias that can arise in observational settings ( 27 ; 15 ) . Nevertheless, this partitioning of time introduces additional methodological challenges. A first challenge arises from the increase in model dimensionality, as temporal segmentation typically multiplies the number of variables and, consequently, the number of parameters to be estimated. Several studies have investigated this issue from a statistical standpoint, quantifying the information loss associated with time discretization when the underlying process evolves in continuous time, and proposing estimation methods designed to address the resulting high-dimensional setting ( 28 ; 9 ; 7 ; 1 ) . While certain statistical assumptions may alleviate the dimensionality burden, these assumptions can be restrictive. The proportional hazards assumption, for example, is frequently used but has been subject to substantial criticism ( 19 ; 17 ) . Another challenge arises from the fact that sometimes, in practice, relatively few patients may initiate treatment during the first study period. To overcome this problem, the notion of grace period has been introduced. This concept can be accommodated within estimation methods such as cloning-censoring-weighting (CCW) ( 3 ) . 30 discussed grace periods in a broader setting and defined it mathematically. Current reporting guidelines for studies emulating randomized trials highlight the need to specify the identifiability assumptions of the causal effect of interest ( 4 ) . Nevertheless, they do not explicitly call for a description of the temporal partitioning strategy adopted, nor for an analysis of its implications for the causal relationship between treatment and outcome within each time period. More generally, these guidelines do not explicitly recommend the inclusion of a causal graph as part of the reporting framework. As a consequence, it is often unclear if conditional exhangeability assumptions commonly invoked in trial emulation translate into constraints within a causal graph, particularly regarding temporal partitioning. This ambiguity also arises when using CCW, as the causal relationship between treatment and outcome within a given time interval was not explicitly articulated in its foundational paper ( 3 ) . As a consequence, it remains unclear whether the assumptions underlying CCW imply that treatment causally affects the outcome within the same time period, that the outcome may influence treatment, or that no specific within-period causal relation is assumed. Clarifying this issue is crucial, as the literature does not adopt a uniform position. Some studies assume the outcome to influence treatment within a time interval ( 27 ; 12 ) , whereas others assume that treatment influences the outcome within that same interval ( 30 ) . These alternative assumptions correspond to distinct graphical structures and distinct choices of temporal partitioning. Making the graphical implications of the CCW assumptions explicit therefore allows researchers to assess their plausibility in specific applications and, in turn, to more rigorously evaluate the appropriateness and validity of applying CCW in a given context. The objective of this article is to provide methodological guidance on time partitioning in the context of target trial emulation. The article is organized into three main sections. Section 2 introduces the framework of structural causal models (SCMs), while Sections 3 and 4 present two hypothetical examples of trial emulation designed to illustrate the challenges associated with time partitioning. These two sections follow the same structure: a description of the clinical scenario, its mathematical formulation, a discussion of the implications of time partitioning, and an evaluation of the validity of the CCW approach in this context. 2 Causal Framework and Notation Our study relies on the SCM framework, which popularized the use of causal graphs known as directed acyclic graphs (DAGs) ( 24 ) . In a DAG, direct causal relationships between variables are encoded through directed edges from causes to effects. The d-separation criterion provides a graphical rule for identifying conditional independence relations implied by the DAG, which must be satisfied by any distribution generated by a system compatible with the DAG. Another central feature of the SCM framework is the do-operator, which encodes an intervention that sets a variable to a given value while leaving the rest of the system unchanged. The do-operator appears in the formal mathematical expression of the causal effect, referred to as the query. Based on the causal assumptions encoded in the DAG, the query can be modified using the rules of do-calculus in order to remove its do-operators ( 23 ) . The resulting expression, known as the estimand, 1 1 1 It is important to note that the notion of an estimand varies across the literature. Under the ICH E9 R1, an estimand is defined as ”a precise description of the treatment effect reflecting the clinical question posed by a given clinical trial objective” ( 8 ) . This definition emphasizes a clear and unambiguous articulation of the research question, rather than a formal mathematical representation. In contrast, some scientific articles define the estimand as a ”causal parameter” that formally encodes the research question, a notion that aligns more closely with the query in the SCM framework ( 21 ) . is composed of probabilities derived solely from the observed data distribution. Therefore, the observed data can be used to estimate the causal effect whenever the causal query can be expressed as an estimand and the causal effect is called “identifiable”. Throughout this article, the letter X denotes the exposure of interest (treatment) and the letter Y denotes the outcome (death). Uppercase letters represent random variables and lowercase letters represent particular realizations of those variables. We consider the study duration to be partitioned into periods indexed from 1 to T (for a given patient, the first period begins when the inclusion criteria are met). When a variable is represented over time, a subscript will indicate the period to which it refers. For example, X_{2} denotes the treatment received during the second period of the study. To simplify notations, we may use a condition in the subscript to refer to multiple periods between 1 and T

Read the complete text